StockData
Burning Rock Biotech Ltd logo

Burning Rock Biotech Ltd (BNR) stock

BNRNasdaqServices-Medical Laboratories
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$13.24−0.08 (-0.60%)

Close on Nov 20, 2026Market cap $144.13MP/E –Yield –

Burning Rock Biotech net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -CN¥55.35M. The highest annual figure on record is -CN¥55.35M in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-CN¥55.35M–
FY2024Dec 31, 2024-CN¥346.63M–
FY2023Dec 31, 2023-CN¥653.69M–
FY2022Dec 31, 2022-CN¥971.23M–
FY2021Dec 31, 2021-CN¥796.70M–
FY2020Dec 31, 2020-CN¥407.24M–
FY2019Dec 31, 2019-CN¥169.16M–
FY2018Dec 31, 2018-CN¥177.50M–

More Burning Rock Biotech figures

See a number that looks wrong?